Disclosure 0001214659-26-011541-1

SEC FORM 4

$2,201.28

Aquestive Therapeutics, Inc. (AQST)

Acquisition (code X) of 2,293 shares at $0.96 per share.

Reporting Person Boyd Peter E. · Officer Title Chief People Officer · Transaction Code X

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001214659-26-011541 · filed 2026-09-10 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Aquestive Therapeutics, Inc. (AQST)." Disclosed 2026-09-10. https://desqlong.com/cards/0001214659-26-011541-1 (retrieved 2026-09-26).